首页> 美国卫生研究院文献>Diabetes Metabolic Syndrome and Obesity: Targets and Therapy >Diabetes and dyslipidemia: characterizing lipoprotein metabolism
【2h】

Diabetes and dyslipidemia: characterizing lipoprotein metabolism

机译:糖尿病和血脂异常:表征脂蛋白代谢

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Premature atherosclerosis in diabetes accounts for much of the decreased life span. New treatments have reduced this risk considerably. This review explores the relationship among the disturbances in glucose, lipid, and bile salt metabolic pathways that occur in diabetes. In particular, excess nutrient intake and starvation have major metabolic effects, which have allowed us new insights into the disturbance that occurs in diabetes. Metabolic regulators such as the forkhead transcription factors, the farnesyl X transcription factors, and the fibroblast growth factors have become important players in our understanding of the dysregulation of metabolism in diabetes and overnutrition. The disturbed regulation of lipoprotein metabolism in both the intestine and the liver has been more clearly defined over the past few years, and the atherogenicity of the triglyceride-rich lipoproteins, and – in tandem – low levels of high-density lipoproteins, is seen now as very important. New information on the apolipoproteins that control lipoprotein lipase activity has been obtained. This is an exciting time in the battle to defeat diabetic atherosclerosis.
机译:糖尿病中的过早动脉粥样硬化是寿命缩短的主要原因。新疗法大大降低了这种风险。这篇综述探讨了糖尿病中葡萄糖,脂质和胆盐代谢途径的紊乱之间的关系。尤其是过多的营养摄入和饥饿会对代谢产生重大影响,这使我们对糖尿病发生的疾病有了新的认识。代谢调节剂,如前叉转录因子,法呢基X转录因子和成纤维细胞生长因子,已成为我们了解糖尿病和营养过度代谢异常的重要角色。在过去的几年中,对肠道和肝脏中脂蛋白代谢紊乱的调节已得到更清晰的定义,现在可以看到富含甘油三酸酯的脂蛋白的动脉粥样硬化性,以及一前一后的低密度高密度脂蛋白一样重要已获得有关控制脂蛋白脂肪酶活性的载脂蛋白的新信息。这是战胜糖尿病动脉粥样硬化的激动人心的时刻。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号